| Evaluation of biological variation of glycated albumin (GA) and fructosamine in healthy subjects, Montagnana M, Paleari R, Danese E, Salvagno GL, Lippi G, Guidi GC and Mosca A, 2013, Clin Chim Acta, 423, 1-4 | 2.3 | 6.3 | Mixed | Healthy (excl pregnant) | Plasma |
| Biological variability of 26 clinical chemistry analytes in elderly people, Fraser CG., Cummings ST., Wilkinson SP., Neville RG., Knox JDE, Ho O and MacWalter RS, 1989, Clin Chem, 35, 783-6 | 4.6 | 3.8 | Mixed | Healthy (excl pregnant) | Serum |
| Assay of serum fructosamine that minimizes standardization and matrix problems: use to asses components of biological variation, Howey JEA, Browning MCk, Fraser CG., 1987, Clin Chem, 33, 269-72 | 5.3 | 9.3 | Mixed | Healthy (excl pregnant) | Serum |
| Total short-term variability in biomarkers of hyperglycemia in older adults, Parrinello CM, Lutsey PL, Couper D, Eckfeldt JH, Steffes MW, Coresh J and Selvin E, 2015, Clin Chem, 61, 1540-1 | 3.4 | 8.5 | Mixed | Healthy (excl pregnant) | Serum |
| Biological variation in glycated proteins, Davie SJ, Whiting KL, Gould BJ., 1993, Ann Clin Biochem, 30, 260-64 | 2.2 | 4.3 | Mixed | Healthy (excl pregnant) | Serum |
| Clinical utility of assays of glycosilated haemoglobin and serum fructosamine comapred: use of data on biological variation, Howey JEA, Bennet WM, Browning MCK, Jung RT and Fraser CG, 1989, Diabetic Medicine, 6, 793-6 | 10.7 | 19.6 | Mixed | Non-healthy (excl pregnant) | Serum |
| Serum fructosamine and glycosylated haemoglobin in the monitoring of glycaemic control in insulin-dependent diabetic outpatients, Watts CF, Morris RW, Goodland FC, Kubal C and Shaw KM, 1989, Practical Diabetes, 6, 159-63 | 15.1 | | Mixed | Non-healthy (excl pregnant) | Serum |
| Total short-term variability in biomarkers of hyperglycemia in older adults, Parrinello CM, Lutsey PL, Couper D, Eckfeldt JH, Steffes MW, Coresh J and Selvin E, 2015, Clin Chem, 61, 1540-1 | 3.7 | 14.8 | Mixed | Non-healthy (excl pregnant) | Serum |
